bibliographic entry 6351776 [be/6351776]
https://w3id.org/oc/corpus/be/6351776

is a
content
  • Bendell, JC, Rodon, J, Burris, HA, de Jonge, M, Verweij, J, Birle, D, Demanse, D, De Buck, SS, Ru, QC, Peters, M, Goldbrunner, M, Baselga, J. Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors, J Clin Oncol, 2012, 30, 282, 290, PMID: 22162589
references